Ivermectin Versus Albendazole for Chronic Strongyloidiasis

• Status: Completed
• Trial end date: 2010-04-01
• Target enrollment: 0
• Participant gender: All

Summary

A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Collaborator: Atlantic Laboratory Ltd
• Treatments: Albendazole; Ivermectin

Criteria

Inclusion Criteria:

• Patients with positive strongyloides larva in the stool

Exclusion Criteria:

• Pregnancy

• Lactating women

• Known allergy to any study drug